WASHINGTON, Jan. 8 (TNSFR) -- The U.S. Food and Drug Administration (FDA) has released a draft guidance aimed at supporting the development of drugs for optical imaging, intended to assist in surgical procedures. These drugs, used alongside imaging devices, are designed to aid in the intraoperative detection of pathologies, such as tumors, and enhance the visibility of normal anatomical structures.

The guidance outlines clinical trial design features that can help pharmaceutical sp . . .

Click here for more information about our products